We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Prostate-specific antigen 1.5-4.0 ng/mL: a diagnostic challenge and danger zone.
- Authors
Crawford, E David; Moul, Judd W; Rove, Kyle O; Pettaway, Curtis A; Lamerato, Lois E; Hughes, Alexa
- Abstract
What's known on the subject? and What does the study add? Large population screening trials like the ERSPC, PCPT and PLCO have noted that men with seemingly low PSA (even as low as 0.5 ng/dL) still can have prostate cancer. Despite these findings, PSA is still predominantly used as a current indicator for possible presence of prostate cancer rather than also serving as a prognostic marker. This study examines a larger number of men in a diverse US population to determine the prognostic value of a man's baseline or first PSA.
- Publication
BJU international, 2011, Vol 108, Issue 11, p1743
- ISSN
1464-410X
- Publication type
Journal Article
- DOI
10.1111/j.1464-410X.2011.10224.x